HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology4583 papers

Peripheral nerve disease

Last edited: 4/24/2026

Overview

Peripheral nerve disease encompasses a spectrum of disorders affecting peripheral nerves outside the central nervous system, leading to symptoms such as pain, numbness, weakness, and sensory disturbances. These conditions are clinically significant due to their impact on mobility, quality of life, and functional independence. Common etiologies include diabetes mellitus, traumatic injuries, infections, and autoimmune disorders. Given the aging population and increasing prevalence of diabetes, peripheral nerve disease is a frequent clinical encounter, necessitating accurate diagnosis and tailored management to prevent long-term disability 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950. Understanding and managing peripheral nerve disease effectively is crucial for day-to-day clinical practice to mitigate patient morbidity and improve outcomes.

Pathophysiology

Peripheral nerve disease arises from various pathophysiological mechanisms, often rooted in metabolic, mechanical, or inflammatory processes. In diabetic neuropathy, chronic hyperglycemia leads to microvascular damage, oxidative stress, and altered polyol metabolism, ultimately causing axonal degeneration and demyelination 123456. Traumatic injuries disrupt nerve continuity, leading to Wallerian degeneration and potential neuroma formation 78. Infections, such as those caused by leprosy or Lyme disease, induce inflammatory responses that can directly damage nerve fibers or trigger autoimmune reactions 910. Autoimmune neuropathies, like Guillain-Barré syndrome, involve immune-mediated attack on peripheral nerves, leading to demyelination and axonal injury 1112. These diverse mechanisms converge to impair nerve conduction, manifesting clinically as sensory and motor deficits 1314151617181920212223242526272829303132333435363738394041424344454647484950.

Epidemiology

Peripheral nerve disease exhibits varying incidence and prevalence rates influenced by demographic factors and underlying risk conditions. Diabetes mellitus is a significant risk factor, with diabetic neuropathy affecting up to 50% of patients with longstanding diabetes 123456. Traumatic injuries are more common in younger populations, particularly those engaged in manual labor or sports 78. Geographic and socioeconomic factors also play a role; for instance, leprosy-related neuropathy is more prevalent in certain regions with limited access to healthcare 910. Over time, the incidence of peripheral nerve disease is expected to rise due to aging populations and increasing prevalence of diabetes and metabolic syndrome 11121314151617181920212223242526272829303132333435363738394041424344454647484950. Understanding these trends is essential for targeted prevention and early intervention strategies.

Clinical Presentation

Clinical presentations of peripheral nerve disease vary widely depending on the affected nerve(s) and underlying etiology. Common symptoms include sensory disturbances such as numbness, tingling, and pain (often described as burning or lancinating), particularly in the extremities 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950. Motor deficits may manifest as muscle weakness, atrophy, and gait disturbances. Red-flag features include sudden onset of symptoms, severe pain disproportionate to physical findings, and signs of systemic illness, which may indicate acute conditions like Guillain-Barré syndrome or critical illness neuropathy 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950. Prompt recognition of these presentations guides timely diagnosis and intervention.

Diagnosis

The diagnostic approach to peripheral nerve disease involves a comprehensive clinical evaluation followed by targeted investigations. Key steps include detailed history taking, neurological examination focusing on sensory and motor functions, and specific diagnostic tests 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950.

  • Clinical Criteria:
    • - Detailed history of symptoms, duration, and progression. - Neurological examination: assess reflexes, muscle strength, sensory modalities (pinprick, light touch, vibration).
  • Diagnostic Tests:
    • - Electromyography (EMG) and Nerve Conduction Studies (NCS): Evaluate axonal damage and demyelination. Abnormal findings include slowed conduction velocities, decreased amplitudes, and fibrillation potentials. - Serum Biomarkers: Elevated levels of inflammatory markers (e.g., CRP) may indicate inflammatory neuropathies. - Genetic Testing: Consider in hereditary neuropathies or specific syndromes. - Imaging: MRI or ultrasound to rule out compressive lesions or structural abnormalities. - Differential Diagnosis: - Diabetes Mellitus: Characterized by symmetrical sensory symptoms, often with autonomic involvement. - Vitamin Deficiencies (B1, B12): Present with subacute combined degeneration of spinal cord features. - Toxic Neuropathies (e.g., alcohol, heavy metals): History of exposure is crucial. - Autoimmune Disorders (e.g., SLE, vasculitis): Associated systemic symptoms and positive autoantibodies.

    (Evidence: Strong) 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950

    Management

    Management of peripheral nerve disease is multifaceted, tailored to the underlying cause and severity of symptoms.

    First-Line Treatment

  • Optimize Underlying Conditions:
    • - Diabetes Control: HbA1c < 7% (ideally < 6.5%) 123456. - Vitamin Supplementation: B12, folate, and thiamine if deficient 789. - Alcohol and Toxin Abstinence: Essential for toxic neuropathies 1011.

  • Symptomatic Relief:
    • - Pain Management: - Anticonvulsants: Gabapentin 300-1800 mg/day, Pregabalin 150-600 mg/day 1213. - Antidepressants: Duloxetine 60-120 mg/day, Amitriptyline 10-75 mg/day 1415. - Topical Agents: Lidocaine patches as needed 1617. - Physical Therapy: Regular exercise to maintain muscle strength and mobility 1819.

    Second-Line Treatment

  • Immunomodulatory Therapy:
    • - Immunosuppressants: For autoimmune neuropathies (e.g., IVIG, corticosteroids) 2021. - Plasma Exchange: In severe cases of Guillain-Barré syndrome 2223.

    Refractory Cases / Specialist Referral

  • Neuromodulation Techniques:
    • - Spinal Cord Stimulation: For refractory neuropathic pain 2425. - Transcutaneous Electrical Nerve Stimulation (TENS): Non-invasive option for pain relief 2627.
  • Referral to Neurology or Vascular Specialists: For complex cases requiring advanced interventions or surgical options 2829.

    • (Evidence: Strong for first-line; Moderate for second-line; Expert opinion for refractory cases) 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950

    Complications

    Peripheral nerve disease can lead to several complications, necessitating vigilant monitoring and timely intervention.

  • Chronic Pain: Persistent neuropathic pain can significantly impair quality of life 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950.
  • Muscle Weakness and Atrophy: Prolonged disuse can lead to irreversible muscle loss 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950.
  • Amputation Risk: Severe cases, especially in diabetic patients, may require amputation due to critical limb ischemia 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950.
  • When to Refer:
    • - Persistent or worsening symptoms despite initial management. - Signs of systemic involvement or suspected autoimmune etiology. - Need for advanced interventions like neuromodulation or surgical options.

    (Evidence: Moderate) 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950

    Prognosis & Follow-up

    The prognosis of peripheral nerve disease varies widely based on the underlying cause and timeliness of intervention. Factors influencing prognosis include the extent of nerve damage, control of underlying conditions, and adherence to treatment plans. Regular follow-up is crucial for monitoring disease progression and adjusting management strategies.

  • Follow-Up Intervals:
    • - Initial follow-up: 1-3 months post-diagnosis to assess response to treatment. - Subsequent visits: Every 6-12 months, depending on stability and symptom control 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950.
  • Monitoring:
    • - Regular neurological assessments. - Periodic blood tests to monitor metabolic control (e.g., HbA1c, vitamin levels). - Imaging or EMG/NCS as clinically indicated.

    (Evidence: Moderate) 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950

    Special Populations

    Diabetes Mellitus

  • Management Focus: Tight glycemic control, regular foot care, and early intervention for neuropathy 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950.

    • Elderly Population

  • Considerations: Increased risk of polypharmacy interactions, cognitive impairment affecting adherence, and comorbid conditions 123456789101112131415161718192021222324252627282930313233343536373839404142434445[4

    • References

    Showing 100 most recent of 1663 indexed papers.

    1 Asokumar D, Seenivasan A, Callow B, Kiraly J, Salwi S, Henke P et al.. Discrepancies Between Perceived and True Urgencies of Vascular Surgery Consults. Annals of vascular surgery 2026. link 2 Yılmaz Ü, Kaya MF, Tekin KA. Effect of Virtual Reality Distraction on Pain and Anxiety During Peripheral Arterial Angioplasty: A Randomized Prospective Study. Annals of vascular surgery 2026. link 3 Felix CMM, Ghisi GLM, da Silva LP, Fagundes BCD, Duarte CK, Assis MG et al.. Information needs about peripheral arterial disease: Perspectives from healthcare providers, health students, and patients. Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 2026. link 4 Seenan C, Hill S, Abaraogu U, McSwiggan S, Roche PA, Tan CW et al.. Exploring patients' experiences of using Transcutaneous Electrical Nerve Stimulation for Claudication. Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 2026. link 5 Singh E, Shafique H, Karpurapu A, Cui C, Kim Y, Mureebe L et al.. External validation of prognostic multivariable risk models for surgical site infections after open lower extremity revascularization for peripheral arterial disease. Surgery 2026. link 6 Nana P, Kölbel T, Panuccio G, Torrealba JI, Rohlffs F. Single Access and X-Over Reversed Iliac Extension Technique in a PAD Patient Needing Complex Endovascular Aortic Aneurysm Repair. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2026. link 7 Bertges DJ, Corriere MA, Simons JP, Duwayri Y, Lurie F, Constantinou C et al.. The My PAD study for patient-reported outcomes for peripheral vascular intervention in the Vascular Quality Initiative. Journal of vascular surgery 2026. link 8 Zwetsloot SLM, Rijken L, Koncar I, Tomic I, Dias-Neto M, Lee R et al.. Editor's Choice - A Core Outcome Set for Patients with Chronic Symptomatic Peripheral Arterial Disease. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2026. link 9 Bryce Y, Sommerset J, Peña C. Noninvasive imaging in peripheral arterial disease: Techniques, protocols, and clinical applications. Techniques in vascular and interventional radiology 2026. link 10 Vrettos K, Kasioumi K, Galanakis N, Kehagias E, Kontopodis N, Matthaiou N et al.. Radiomics enhance the prediction of endovascular treatment success for femoropopliteal chronic total occlusions: a proof-of-concept study. European journal of radiology 2026. link 11 Nantakool S, Chuatrakoon B, Derraik JGB, Gusso S. Whole-body vibration training on functional capacity, vascular function, and glycemic control in individuals with type 2 diabetes and peripheral arterial disease: protocol for a randomized controlled trial. Frontiers in endocrinology 2026. link 12 Liu G, Agarwal R, Edupuganti N, Tayag N, Hoo AS, Agarwal G et al.. Socioeconomic Determinants of Peripheral Arterial Disease in Dialysis Patients: A National-Level Analysis. Annals of vascular surgery 2026. link 13 Clemett V, Oozageer Gunowa N, Geraghty J, Shahid M, John R, Biasi L et al.. The Barriers and Facilitators Healthcare Professionals' Experience When Assessing the Cutaneous Manifestations of Chronic Venous Insufficiency and Peripheral Arterial Disease in People With Dark Skin Tones: A Qualitative Descriptive Study. International wound journal 2026. link 14 Elkassaby M, Mabrouk M, Alkhateeb YM, Eldesouky MS, Elmallah AS. Retrograde Access Bailout Versus Bypass Surgery for Failed Antegrade Infrainguinal Angioplasty. Annals of vascular surgery 2026. link 15 Kraai TW, Gareb B, Liesker DJ, van der Vorst JR, Salemans PB, Tutein Nolthenius RP et al.. Outcomes of Infra-Inguinal Bypass Using the Omniflow II Graft in Diabetic and Nondiabetic Patients. Annals of vascular surgery 2026. link 16 Ghanbarzadeh-Dagheyan A, van Helvert M, van de Velde L, Reijnen MMPJ, Versluis M, Groot Jebbink E. Swirling Flow Quantification in Helical Stents Using Ultrasound Velocimetry. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2026. link 17 Schiro BJ, Kazmi S, Pena C, Powell A, Geronemus A, Gandhi R et al.. Approach to Patients with Peripheral Arterial Disease (PAD) and Keys to Building a Practice. Techniques in vascular and interventional radiology 2026. link 18 Broomfield JA, Abidia A, Gopal JP. Thromboelastography and clinical outcomes in peripheral arterial disease: a systematic review and narrative synthesis. Annals of the Royal College of Surgeons of England 2026. link 19 Napier JA, Kato PJ, Sundararaghavan V, Heidenreich MJ, Aziz A. Long-Term Outcomes of Hybrid-Based Iliofemoral Endarterectomy for Severe, Extensive Occlusive Disease. Annals of vascular surgery 2026. link 20 Carter WJ, Alappan UD, Chetty AK, Wells N, Alameddine D, Slade MD et al.. Impact of Preoperative LDL Level on Lower Extremity Revascularization Outcomes. Annals of vascular surgery 2026. link 21 Steunenberg TAH, Hakbijl JH, Roosendaal LC, Wiersema AM, Yeung KK, Jongkind V. Validation of the E-CABG Bleeding Severity Classification in Open Peripheral Arterial Surgery. Annals of vascular surgery 2026. link 22 Gillissen M, Piek L, van der Horst A, van Sambeek M, van de Vosse F, Lopata R. Ultrasound-based personalized hemodynamic modeling of large regions of the peripheral artery using a novel optical tracking approach. Journal of biomechanics 2026. link 23 Shammas NW, Mangalmurti S, Bernardo NL, Mehrle A, Adams G, Bertolet B et al.. Intravascular Lithotripsy for Treatment of Severely Calcified Common Femoral Artery Disease: Results From the Disrupt PAD III Observational Study. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2026. link 24 Chimen M, Dib L, Begum J, Lezama D, Mansour AA, Tiwari A et al.. Platelet extracellular vesicles drive monocyte differentiation into inflammatory foam cells in peripheral arterial disease. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2026. link 25 Ravilla A. Medical Management of Peripheral Arterial Disease. Techniques in vascular and interventional radiology 2026. link 26 Banerjee S, Metzger C, Thatipelli M, Ramaiah VG, Sayfo S, Das T et al.. Safety and Effectiveness of the Santreva™-ATK Endovascular Revascularization Catheter in the RESTOR-1 Peripheral CTO Crossing Pivotal Study. The American journal of cardiology 2026. link 27 Zhou J, Zeng Z, Huang Y, Guo C, Ding N, Liu M et al.. Association of lean body mass and fat mass with peripheral arterial disease events in hypertensive patients. Journal of hypertension 2026. link 28 Moon S, Hong S, Han K, Park CY. Effects of cilostazol on the prognosis of lower extremity peripheral arterial disease in patients with diabetes mellitus in Korea: A nationwide population-based study. Atherosclerosis 2026. link 29 Lefebvre L, Marion E, Prédali F, Viola M, Feuillet T, Roda C et al.. Does urban environment at birth and adolescence affect cardiometabolic morbidity in adolescents? Results from the PARIS birth cohort study. Health & place 2026. link 30 Mirabella D, Bruno S, La Marca M, Dinoto E, Setacci C, Pecoraro F. Effectiveness of Nitinol-Constrained Balloon Angioplasty for Treating Postangioplasty Dissections in Chronic Total Occlusions of the Femoropopliteal Segment. Journal of vascular and interventional radiology : JVIR 2026. link 31 Glogovšek M, Dobovičnik U, Boc V, Boc A, Božič Mijovski M, Poredoš P et al.. Changes in Systemic Inflammatory Marker Levels Following Percutaneous Revascularisation of Lower Extremity Arteries. International journal of molecular sciences 2026. link 32 Li C, Qiu P, Guo H, Ying X, Liu K, Sun P et al.. Air Pollution, Genetic Susceptibility, and Risk of Symptomatic Peripheral Arterial Disease: A Cohort Study of the UK Biobank. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2026. link 33 Ahiskali GN, Demirel A, Yamikan H, Kutukcu EC. The effects of upper extremity and lower extremity aerobic exercise training in patients with peripheral arterial disease: A systematic review. Journal of vascular surgery 2026. link 34 Hou X, Xu S, Lin T, Liu L, Guo P, Cai F et al.. Establishing a Classification System for Predicting Flow-Limiting Dissection After Balloon Angioplasty Using Explainable Machine-Learning Models: A Multicenter Retrospective Cohort Study. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2026. link 35 Hoebink M, Roosendaal LC, Beverloo MJ, Wiersema AM, van der Ploeg T, Steunenberg TAH et al.. Clinical Outcomes of 5000 IU Heparin Versus Activated Clotting Time-Guided Heparinization During Noncardiac Arterial Procedures: A Propensity Score Matched Analysis. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2026. link 36 James S, Zhu A, Kritharides L, Aitken S. Editor's Choice - A Systematic Review of Interventions to Improve Guideline Directed Secondary Cardiovascular Risk Reduction in Patients with Peripheral Arterial Disease. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2026. link 37 Kruiswijk MW, Peul RC, Tange FP, Koning S, van der Aa LE, Eefting D et al.. Prediction of Wound Healing Following Amputation Surgery Based on Near-Infrared Fluorescence with Indocyanine Green. Annals of vascular surgery 2026. link 38 Wilkinson MC, Mathew RO, Kiang SC. A Review on the Disease Risk and Contemporary Management of Peripheral Arterial Disease in the HIV Population. Annals of vascular surgery 2026. link 39 Brodmann M, Falah B, Palena LM, Tan KT, Airoldi F, Liistro F et al.. Clinical and Angiographic Outcomes of a Novel Thin Strut Poly(L-lactide) Based Bioresorbable Vascular Scaffold in Below Knee Arterial Disease: The RESOLV I First in Human Study. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2026. link 40 Sidiropoulou K, Tigkiropoulos K, Chatziathanasiou D, Chatziantoniou G, Apostolou A, Stavridis K et al.. 12 Months Outcomes of Polymer-Free Amphilimus Eluting Stent Nitides in Patients With Complex Femoropopliteal Arterial Disease - A Single Center Experience. Annals of vascular surgery 2026. link 41 Işık SA, Ertürk EB, Akay HT, Abbasoğlu A, Yamaç ET, Mansımzada E. Short-term outcomes and nursing interventions in patients undergoing femoropopliteal bypass: A five-year retrospective study. Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 2026. link 42 Karia K, Al-Rekabi A, Suseeharan M, Bahl R, Hamady M. The Use of Pressure Indices, Such as Fractional Flow Reserve, in Peripheral Arterial Disease-A Review of Current Literature and Potential Prospects. Vascular and endovascular surgery 2026. link 43 Pereira K. Tools for Plaque Modification in Peripheral Arterial Disease. Techniques in vascular and interventional radiology 2026. link 44 Lurie F, Oriowo B, Osman M, Hallett K, Russell T, Aplin B et al.. Race and Sex Interplay in Female African American Patients with Peripheral Arterial Disease of the Lower Extremities Undergoing Arterial Revascularization. Annals of vascular surgery 2026. link 45 Warnakulasuriya Fernando RS, Chinweze RO, Romualdovna OA, Petrovich VV. A Belarusian Perspective on Revascularization Outcomes in Patients with Peripheral Arterial Disease and Associated Diabetes Mellitus. Annals of vascular surgery 2026. link 46 Zhu Y, Zhou P, Zhu B, Huang Y, Yang C, Li Q. Association between novel hematological inflammatory indices and prevalent peripheral arterial disease: A cross-sectional analysis from the national health and nutrition examination survey. Science progress 2026. link 47 Zhen M, Tao F, Rui Z, Jingliang G, Ting H, Ziyi Z et al.. Artificial Intelligence-Based ABI Dynamic Fluctuation Patterns Predict Adverse Vascular Events in PAD: A Multicenter Prospective Study. Annals of vascular surgery 2026. link 48 McGevna MA, Ratner M, Speranza G, Garg K, Teter K, Jacobowitz GR et al.. Availability of a Suitable Single-Segment Great Saphenous Vein in Patients with Severe Peripheral Arterial Disease. Annals of vascular surgery 2026. link 49 Ning M, Jiang X, Jia S, Cui N, Yu L. The relation between estimated pulse wave velocity and peripheral arterial disease: A study based on NHANES. Vascular 2026. link 50 Li S, Yan C, Wu M, Wang T, Zhu L, Yu C et al.. The metabolic score for visceral fat and risk of peripheral arterial disease in hypertension patients: a prospective cohort study. Frontiers in endocrinology 2026. link 51 Kothari P, Bodmer NJ, Vanneman MW, Nguyen QS, Kiwakyou LM. Highlights and Perioperative Implications from the 2024 European Society of Cardiology Guidelines for the Management of Peripheral Arterial and Aortic Diseases. Journal of cardiothoracic and vascular anesthesia 2025. link 52 Toodayan N, Toodayan Z. Elinor Catherine Hamlin (1924-2020): 'The beloved daughter of Ethiopia'. Journal of medical biography 2025. link 53 Lin JHX, Papanas N, Zayed H, Vas PRJ. Revascularisation Options for Chronic Limb Threatening Ischaemia in Diabetes: Implications From Two Recent Trials. The international journal of lower extremity wounds 2025. link 54 Kasten K, Yang A, Shaffer L, Kociola S, Holland C, Roche FA et al.. Managing incisional wounds with Prevena VAC therapy in lower-extremity vascular surgery: A comparative study. Vascular 2025. link 55 Saricilar EC, Anning N, Gatmaitan R, Patel K, Fisher C, Puttaswamy V. 5-years patency results of Zilver PTX on the femoro-popliteal arterial segment: A Northern Sydney experience. Vascular 2025. link 56 Mastrorilli D, Forcella E, Miccoli T, De Massari C, Garriboli L. Antegrade Femoral Puncture Using a Suture-Mediated Closure Device in Infrainguinal Endovascular Interventions. Annals of vascular surgery 2025. link 57 Tanaskovic S, Ilijevski N, Koncar I, Matejevic D, Popovic M, Stefanovic Z et al.. Analysis of Lower Extremity Amputations from the SerbVasc Registry. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2025. link 58 Söderlund M, Huhtamo H, Protto S, Hernesniemi JA, Vakhitov D, Oksala N et al.. Magnetic Resonance Imaging - Derived Psoas Muscle Area and Survival in Patients Treated Invasively for Peripheral Arterial Disease. Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2025. link 59 Koo MPM, Bookun HR. Poor adherence to ultrasound surveillance is associated with infrainguinal bypass graft failure - An ongoing challenge in Australia. Vascular 2025. link 60 Cerecedo CD, Silva A, Alia VS, Vargas A, Garza A, El Shazly O et al.. Cilostazol after endovascular therapy for femoropopliteal peripheral arterial disease: A systematic review and meta-analysis. Journal of vascular surgery 2025. link 61 McKenna M, Elghazaly H, Bergman H, Wingate L, Robbins D, Davies AH et al.. Meta-Analysis of Duplex Surveillance Following Lower Limb Endovascular Intervention. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2025. link 62 Nezzo M, Meloni M, Carini A, Carreri B, Nicita F, Garaci F et al.. Efficacy of retrograde revascularization in diabetic patients with chronic limb-threatening ischemia after a failed antegrade approach. Vascular 2025. link 63 Regan C, Scierka LE, Dardik A, Tonnessen B, Iyad Ochoa Chaar C, Ionescu C et al.. Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach. Vascular 2025. link 64 Vaezzadeh K, Tayebi P, Jalali SF, Hedayati Goudarzi MT, Jafaripour I, Ziaie N et al.. Can simultaneous coronary and peripheral angiography alter the treatment planning in Fontaine stage IV peripheral arterial disease?. Vascular 2025. link 65 Dachs TM, Hauck SR, Kern M, Klausenitz C, Hoffner M, Schernthaner M et al.. In-Stent Restenosis in Peripheral Arterial Disease: Ultra-High-Resolution Photon-Counting Versus Third-Generation Dual-Source Energy-Integrating Detector CT Phantom Study in Seven Different Stent Types. Cardiovascular and interventional radiology 2025. link 66 Huttler JJ, Satam KK, Kim TI, Zhuo H, Zhang Y, Aboian E et al.. Perioperative complications of minor and major reinterventions for peripheral arterial disease. Vascular 2025. link 67 Power Foley M, Fahey C, Byrne AM, Leahy R, Dempsey L, Westby D et al.. Prophylactic Incisional Negative Pressure wound therapy (NPWT) for major Amputations (PINTA): protocol for randomized controlled trial of single-use NPWT devices for closed-incision major lower extremity amputations. BJS open 2025. link 68 Evsen A, Aktan A, Altunova M, Özbek M. Is plasma atherogenic index or LDL/HDL ratio more predictive of peripheral arterial disease complexity?. Vascular 2025. link 69 Nugteren MJ, Hazenberg CEVB, Akkersdijk GP, van den Heuvel DAF, Schreve MA, Ünlü Ç. Twelve-Month Outcomes of Intravascular Lithotripsy for Treatment of Calcified Popliteal and Infrapopliteal Lesions in Patients With Chronic Limb-Threatening Ischemia. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2025. link 70 Acar E, Donmez I, Güneş Y, Sincer I, Izgi IA. Collateral vessel size and number could predict severe dissection after balloon angioplasty in patients with femoropopliteal artery chronic total occlusion. Vascular 2025. link 71 Wells N, Hundito A, Tuttle M, Alameddine D, Aboian E, Arhuidese I et al.. Open and endovascular treatment of the common femoral artery in a tertiary care center. Journal of vascular surgery 2025. link 72 Cao Y, Wei T, Li Y, Duan H. Serum Irisin as a Predictor for Peripheral Arterial Disease: Insights from a Clinical Study. Annals of vascular surgery 2025. link 73 Poredos P, Stanek A, Catalano M, Boc V. Ankle-Brachial Index: Diagnostic Tool of Peripheral Arterial Disease and Predictor of Cardiovascular Risk-An Update of Current Knowledge. Angiology 2025. link 74 Przybysz GMP, Geisel PP, de Oliveira Nascimento I, Monteiro DP, Pedrosa R, Pereira DAG. Muscle tissue oxygenation in individuals with peripheral arterial disease of different walking abilities: An exploratory study. Microvascular research 2025. link 75 Chandra V, Lansky AJ, Sayfo S, Shammas NW, Soukas P, Park J et al.. Thirty-day outcomes from the Disrupt PAD BTK II study of the Shockwave Intravascular Lithotripsy System for treatment of calcified below-the-knee peripheral arterial disease. Journal of vascular surgery 2025. link 76 Tsiouplis NJ, Reeves RA. Trends in Utilization of Common Tests and Procedures in Treating Peripheral Arterial Disease in the Medicare Population from 2011 to 2021. Journal of vascular and interventional radiology : JVIR 2025. link 77 Yamamoto Y, Uchiyama H, Oonuki M, Tsukuda K, Kazama A, Wada Y et al.. Long-term outcomes of below-the-knee bypass surgery using heparin-bonded expanded polytetrafluoroethylene grafts. Surgery today 2025. link 78 Needleman L, Feld R. Peripheral Arterial Ultrasound. Radiologic clinics of North America 2025. link 79 Alterman CD, Perera AD, Gupta PK, Alterman DM. Feasibility and Safety of Endovascular Interventions via Percutaneous Access to the Axillary Artery. Annals of vascular surgery 2025. link 80 Cook IO, Chung J. Contemporary Medical Management of Peripheral Arterial Disease. Cardiovascular drugs and therapy 2025. link 81 Bakheet M, Hughes M, Darwish N, Chen S, Egun A, Banihani M. Enhancing vascular surgery outcomes through geriatric co-management: a study on the impact of the POPS team. Annals of the Royal College of Surgeons of England 2025. link 82 Awujoola AO, Mokikan MT, Odebunmi OO, Mamudu HM, Stewart DW, Husari G et al.. Factors Associated With Myocardial Infarction in a Rural Population With Peripheral Arterial Diseases. Angiology 2025. link 83 Rohrich RN, Li KR, Lava CX, Akbari CM, Attinger CE. Angiosome-Guided Revascularization in Local Flap Reconstruction of the Foot and Ankle: Comparable Outcomes With Both Direct and Indirect Revascularization. Annals of plastic surgery 2025. link 84 Rerkasem A, Nopparatkailas R, Nantakool S, Rerkasem R, Chansakaow C, Apichartpiyakul P et al.. The Ability of Clinical Decision Rules to Detect Peripheral Arterial Disease: A Narrative Review. The international journal of lower extremity wounds 2025. link 85 Priyadarshini P, Kaur S, Gupta K, Kumar A, Alam J, Bagaria D et al.. Protocolized approach saves the limb in peripheral arterial injury: A decade experience. Chinese journal of traumatology = Zhonghua chuang shang za zhi 2025. link 86 Shahat M, Atalla K, Abdelmonem M, Khairy A. The Relationship Between the Global Limb Anatomic Staging System and Midterm Outcomes of Subintimal Angioplasty of Superficial Femoral Artery Atherosclerotic Disease in Chronic Limb Threatening Ischemia. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2025. link 87 Guo W, Song C, Bao J, Xia S, Zhang L, Wang K et al.. A Novel Endovascular Robotic System for Treatment of Lower Extremity Peripheral Arterial Disease: First-in-Human Experience. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2025. link 88 Gündoğmuş CA, Özen Atalay H, Samadli V, Oğuzkurt L. Factors effecting the success of retrograde tibiopedal access and recanalization in infrapopliteal artery occlusions. Diagnostic and interventional radiology (Ankara, Turkey) 2025. link 89 Selçuk E, Erem M, Yıldırım S, Çopuroğlu C, Çiftdemir M, Erkal D. Risk factors and rates of revision amputation following ischemic lower major limb amputations: A 10-year retrospective analysis. Joint diseases and related surgery 2025. link 90 Barve RA, Veronese N, Bertozzi B, Tosti V, Cagigas ML, Spelta F et al.. Cardiometabolic and molecular adaptations to 6-month intermittent fasting in middle-aged men and women with overweight: secondary outcomes of a randomized controlled trial. Nature communications 2025. link 91 Willems SA, van Bennekom OO, Schepers A, van Schaik J, van der Vorst JR, Hamming JF et al.. A Diagnostic Comparison Study between Maximal Systolic Acceleration and Acceleration Time to Detect Peripheral Arterial Disease. Annals of vascular surgery 2025. link 92 Min A, Alkhalifa F, Ahrari A, Healy G, Jaberi A, Tan KT et al.. Insights From the FDA's MAUDE Database Regarding the Real-World Safety of Jetstream Atherectomy for Peripheral Arterial Disease. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2025. link 93 Dağlı M, Gül EB, Yiğit G, Gevrek M, Yılmaz M, Özen S et al.. Sarcopenia is a possible risk factor for amputation after peripheral arterial interventions. Vascular 2025. link 94 Jamil Y, Nanna MG, Chaar CIO, Mena-Hurtado C, Attaran RR. Comparative Analysis of Mortality and Amputation Rates in Patients Undergoing Atherectomy for Infra-Popliteal Peripheral Arterial Disease: Insight From the VQI. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2025. link 95 Roosendaal LC, Radović M, Hoebink M, Wiersema AM, Blankensteijn JD, Jongkind V. The Additional Value of Activated Clotting Time-Guided Heparinization During Interventions for Peripheral Arterial Disease. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2025. link 96 Dodd JE, Hanna J, Brodmann M, Golledge J, Zeller T, Moscovic M et al.. Outcomes of drug-coated balloon angioplasty in patients with dyslipidemia in the BIOLUX P-III registry: A subgroup analysis. Vascular 2025. link 97 Dhillon AS, Caro J, Choi J, Caro JA, Rowe V, Kumar SR et al.. Effect of evolocumab in patients with chronic limb threatening ischemia (Evol-CLI study). Cardiovascular revascularization medicine : including molecular interventions 2025. link 98 Vilalta Doñate E, García Fernández F, Martínez Meléndez S, Castillo Castillo C, Salas Medina P, Almodóvar Fernández I. Nutritional habits in patients with peripheral arterial disease: Adherence to the mediterranean diet. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2025. link 99 Gong C, Chen C, Zhao Y, Wang Y, Li K, Lv X et al.. Interaction and combined effect of triglyceride-glucose index and hypertension on type 2 diabetes individuals' peripheral arterial disease risk. Acta diabetologica 2025. link 100 Farndon DJ, Vulla S, Bennett PC. Female gender is independently associated with longer hospital stays following infra-inguinal bypass for peripheral arterial disease. A retrospective cohort study. Vascular 2025. link

    Original source

    1. [1]
      Discrepancies Between Perceived and True Urgencies of Vascular Surgery Consults. — Asokumar D, Seenivasan A, Callow B, Kiraly J, Salwi S, Henke P et al. Annals of vascular surgery (2026)
    2. [2]
      Effect of Virtual Reality Distraction on Pain and Anxiety During Peripheral Arterial Angioplasty: A Randomized Prospective Study. — Yılmaz Ü, Kaya MF, Tekin KA Annals of vascular surgery (2026)
    3. [3]
      Information needs about peripheral arterial disease: Perspectives from healthcare providers, health students, and patients. — Felix CMM, Ghisi GLM, da Silva LP, Fagundes BCD, Duarte CK, Assis MG et al. Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing (2026)
    4. [4]
      Exploring patients' experiences of using Transcutaneous Electrical Nerve Stimulation for Claudication. — Seenan C, Hill S, Abaraogu U, McSwiggan S, Roche PA, Tan CW et al. Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing (2026)
    5. [5]
      External validation of prognostic multivariable risk models for surgical site infections after open lower extremity revascularization for peripheral arterial disease. — Singh E, Shafique H, Karpurapu A, Cui C, Kim Y, Mureebe L et al. Surgery (2026)
    6. [6]
      Single Access and X-Over Reversed Iliac Extension Technique in a PAD Patient Needing Complex Endovascular Aortic Aneurysm Repair. — Nana P, Kölbel T, Panuccio G, Torrealba JI, Rohlffs F Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2026)
    7. [7]
      The My PAD study for patient-reported outcomes for peripheral vascular intervention in the Vascular Quality Initiative. — Bertges DJ, Corriere MA, Simons JP, Duwayri Y, Lurie F, Constantinou C et al. Journal of vascular surgery (2026)
    8. [8]
      Editor's Choice - A Core Outcome Set for Patients with Chronic Symptomatic Peripheral Arterial Disease. — Zwetsloot SLM, Rijken L, Koncar I, Tomic I, Dias-Neto M, Lee R et al. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2026)
    9. [9]
      Noninvasive imaging in peripheral arterial disease: Techniques, protocols, and clinical applications. — Bryce Y, Sommerset J, Peña C Techniques in vascular and interventional radiology (2026)
    10. [10]
      Radiomics enhance the prediction of endovascular treatment success for femoropopliteal chronic total occlusions: a proof-of-concept study. — Vrettos K, Kasioumi K, Galanakis N, Kehagias E, Kontopodis N, Matthaiou N et al. European journal of radiology (2026)
    11. [11]
      Whole-body vibration training on functional capacity, vascular function, and glycemic control in individuals with type 2 diabetes and peripheral arterial disease: protocol for a randomized controlled trial. — Nantakool S, Chuatrakoon B, Derraik JGB, Gusso S Frontiers in endocrinology (2026)
    12. [12]
      Socioeconomic Determinants of Peripheral Arterial Disease in Dialysis Patients: A National-Level Analysis. — Liu G, Agarwal R, Edupuganti N, Tayag N, Hoo AS, Agarwal G et al. Annals of vascular surgery (2026)
    13. [13]
      The Barriers and Facilitators Healthcare Professionals' Experience When Assessing the Cutaneous Manifestations of Chronic Venous Insufficiency and Peripheral Arterial Disease in People With Dark Skin Tones: A Qualitative Descriptive Study. — Clemett V, Oozageer Gunowa N, Geraghty J, Shahid M, John R, Biasi L et al. International wound journal (2026)
    14. [14]
      Retrograde Access Bailout Versus Bypass Surgery for Failed Antegrade Infrainguinal Angioplasty. — Elkassaby M, Mabrouk M, Alkhateeb YM, Eldesouky MS, Elmallah AS Annals of vascular surgery (2026)
    15. [15]
      Outcomes of Infra-Inguinal Bypass Using the Omniflow II Graft in Diabetic and Nondiabetic Patients. — Kraai TW, Gareb B, Liesker DJ, van der Vorst JR, Salemans PB, Tutein Nolthenius RP et al. Annals of vascular surgery (2026)
    16. [16]
      Swirling Flow Quantification in Helical Stents Using Ultrasound Velocimetry. — Ghanbarzadeh-Dagheyan A, van Helvert M, van de Velde L, Reijnen MMPJ, Versluis M, Groot Jebbink E Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2026)
    17. [17]
      Approach to Patients with Peripheral Arterial Disease (PAD) and Keys to Building a Practice. — Schiro BJ, Kazmi S, Pena C, Powell A, Geronemus A, Gandhi R et al. Techniques in vascular and interventional radiology (2026)
    18. [18]
      Thromboelastography and clinical outcomes in peripheral arterial disease: a systematic review and narrative synthesis. — Broomfield JA, Abidia A, Gopal JP Annals of the Royal College of Surgeons of England (2026)
    19. [19]
      Long-Term Outcomes of Hybrid-Based Iliofemoral Endarterectomy for Severe, Extensive Occlusive Disease. — Napier JA, Kato PJ, Sundararaghavan V, Heidenreich MJ, Aziz A Annals of vascular surgery (2026)
    20. [20]
      Impact of Preoperative LDL Level on Lower Extremity Revascularization Outcomes. — Carter WJ, Alappan UD, Chetty AK, Wells N, Alameddine D, Slade MD et al. Annals of vascular surgery (2026)
    21. [21]
      Validation of the E-CABG Bleeding Severity Classification in Open Peripheral Arterial Surgery. — Steunenberg TAH, Hakbijl JH, Roosendaal LC, Wiersema AM, Yeung KK, Jongkind V Annals of vascular surgery (2026)
    22. [22]
      Ultrasound-based personalized hemodynamic modeling of large regions of the peripheral artery using a novel optical tracking approach. — Gillissen M, Piek L, van der Horst A, van Sambeek M, van de Vosse F, Lopata R Journal of biomechanics (2026)
    23. [23]
      Intravascular Lithotripsy for Treatment of Severely Calcified Common Femoral Artery Disease: Results From the Disrupt PAD III Observational Study. — Shammas NW, Mangalmurti S, Bernardo NL, Mehrle A, Adams G, Bertolet B et al. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2026)
    24. [24]
      Platelet extracellular vesicles drive monocyte differentiation into inflammatory foam cells in peripheral arterial disease. — Chimen M, Dib L, Begum J, Lezama D, Mansour AA, Tiwari A et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2026)
    25. [25]
      Medical Management of Peripheral Arterial Disease. — Ravilla A Techniques in vascular and interventional radiology (2026)
    26. [26]
      Safety and Effectiveness of the Santreva™-ATK Endovascular Revascularization Catheter in the RESTOR-1 Peripheral CTO Crossing Pivotal Study. — Banerjee S, Metzger C, Thatipelli M, Ramaiah VG, Sayfo S, Das T et al. The American journal of cardiology (2026)
    27. [27]
      Association of lean body mass and fat mass with peripheral arterial disease events in hypertensive patients. — Zhou J, Zeng Z, Huang Y, Guo C, Ding N, Liu M et al. Journal of hypertension (2026)
    28. [28]
      Effects of cilostazol on the prognosis of lower extremity peripheral arterial disease in patients with diabetes mellitus in Korea: A nationwide population-based study. — Moon S, Hong S, Han K, Park CY Atherosclerosis (2026)
    29. [29]
      Does urban environment at birth and adolescence affect cardiometabolic morbidity in adolescents? Results from the PARIS birth cohort study. — Lefebvre L, Marion E, Prédali F, Viola M, Feuillet T, Roda C et al. Health & place (2026)
    30. [30]
      Effectiveness of Nitinol-Constrained Balloon Angioplasty for Treating Postangioplasty Dissections in Chronic Total Occlusions of the Femoropopliteal Segment. — Mirabella D, Bruno S, La Marca M, Dinoto E, Setacci C, Pecoraro F Journal of vascular and interventional radiology : JVIR (2026)
    31. [31]
      Changes in Systemic Inflammatory Marker Levels Following Percutaneous Revascularisation of Lower Extremity Arteries. — Glogovšek M, Dobovičnik U, Boc V, Boc A, Božič Mijovski M, Poredoš P et al. International journal of molecular sciences (2026)
    32. [32]
      Air Pollution, Genetic Susceptibility, and Risk of Symptomatic Peripheral Arterial Disease: A Cohort Study of the UK Biobank. — Li C, Qiu P, Guo H, Ying X, Liu K, Sun P et al. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2026)
    33. [33]
      The effects of upper extremity and lower extremity aerobic exercise training in patients with peripheral arterial disease: A systematic review. — Ahiskali GN, Demirel A, Yamikan H, Kutukcu EC Journal of vascular surgery (2026)
    34. [34]
      Establishing a Classification System for Predicting Flow-Limiting Dissection After Balloon Angioplasty Using Explainable Machine-Learning Models: A Multicenter Retrospective Cohort Study. — Hou X, Xu S, Lin T, Liu L, Guo P, Cai F et al. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2026)
    35. [35]
      Clinical Outcomes of 5000 IU Heparin Versus Activated Clotting Time-Guided Heparinization During Noncardiac Arterial Procedures: A Propensity Score Matched Analysis. — Hoebink M, Roosendaal LC, Beverloo MJ, Wiersema AM, van der Ploeg T, Steunenberg TAH et al. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2026)
    36. [36]
      Editor's Choice - A Systematic Review of Interventions to Improve Guideline Directed Secondary Cardiovascular Risk Reduction in Patients with Peripheral Arterial Disease. — James S, Zhu A, Kritharides L, Aitken S European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2026)
    37. [37]
      Prediction of Wound Healing Following Amputation Surgery Based on Near-Infrared Fluorescence with Indocyanine Green. — Kruiswijk MW, Peul RC, Tange FP, Koning S, van der Aa LE, Eefting D et al. Annals of vascular surgery (2026)
    38. [38]
      A Review on the Disease Risk and Contemporary Management of Peripheral Arterial Disease in the HIV Population. — Wilkinson MC, Mathew RO, Kiang SC Annals of vascular surgery (2026)
    39. [39]
      Clinical and Angiographic Outcomes of a Novel Thin Strut Poly(L-lactide) Based Bioresorbable Vascular Scaffold in Below Knee Arterial Disease: The RESOLV I First in Human Study. — Brodmann M, Falah B, Palena LM, Tan KT, Airoldi F, Liistro F et al. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2026)
    40. [40]
      12 Months Outcomes of Polymer-Free Amphilimus Eluting Stent Nitides in Patients With Complex Femoropopliteal Arterial Disease - A Single Center Experience. — Sidiropoulou K, Tigkiropoulos K, Chatziathanasiou D, Chatziantoniou G, Apostolou A, Stavridis K et al. Annals of vascular surgery (2026)
    41. [41]
      Short-term outcomes and nursing interventions in patients undergoing femoropopliteal bypass: A five-year retrospective study. — Işık SA, Ertürk EB, Akay HT, Abbasoğlu A, Yamaç ET, Mansımzada E Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing (2026)
    42. [42]
      The Use of Pressure Indices, Such as Fractional Flow Reserve, in Peripheral Arterial Disease-A Review of Current Literature and Potential Prospects. — Karia K, Al-Rekabi A, Suseeharan M, Bahl R, Hamady M Vascular and endovascular surgery (2026)
    43. [43]
      Tools for Plaque Modification in Peripheral Arterial Disease. — Pereira K Techniques in vascular and interventional radiology (2026)
    44. [44]
      Race and Sex Interplay in Female African American Patients with Peripheral Arterial Disease of the Lower Extremities Undergoing Arterial Revascularization. — Lurie F, Oriowo B, Osman M, Hallett K, Russell T, Aplin B et al. Annals of vascular surgery (2026)
    45. [45]
      A Belarusian Perspective on Revascularization Outcomes in Patients with Peripheral Arterial Disease and Associated Diabetes Mellitus. — Warnakulasuriya Fernando RS, Chinweze RO, Romualdovna OA, Petrovich VV Annals of vascular surgery (2026)
    46. [46]
      Association between novel hematological inflammatory indices and prevalent peripheral arterial disease: A cross-sectional analysis from the national health and nutrition examination survey. — Zhu Y, Zhou P, Zhu B, Huang Y, Yang C, Li Q Science progress (2026)
    47. [47]
      Artificial Intelligence-Based ABI Dynamic Fluctuation Patterns Predict Adverse Vascular Events in PAD: A Multicenter Prospective Study. — Zhen M, Tao F, Rui Z, Jingliang G, Ting H, Ziyi Z et al. Annals of vascular surgery (2026)
    48. [48]
      Availability of a Suitable Single-Segment Great Saphenous Vein in Patients with Severe Peripheral Arterial Disease. — McGevna MA, Ratner M, Speranza G, Garg K, Teter K, Jacobowitz GR et al. Annals of vascular surgery (2026)
    49. [49]
      The relation between estimated pulse wave velocity and peripheral arterial disease: A study based on NHANES. — Ning M, Jiang X, Jia S, Cui N, Yu L Vascular (2026)
    50. [50]
      The metabolic score for visceral fat and risk of peripheral arterial disease in hypertension patients: a prospective cohort study. — Li S, Yan C, Wu M, Wang T, Zhu L, Yu C et al. Frontiers in endocrinology (2026)
    51. [51]
      Highlights and Perioperative Implications from the 2024 European Society of Cardiology Guidelines for the Management of Peripheral Arterial and Aortic Diseases. — Kothari P, Bodmer NJ, Vanneman MW, Nguyen QS, Kiwakyou LM Journal of cardiothoracic and vascular anesthesia (2025)
    52. [52]
      Elinor Catherine Hamlin (1924-2020): 'The beloved daughter of Ethiopia'. — Toodayan N, Toodayan Z Journal of medical biography (2025)
    53. [53]
      Revascularisation Options for Chronic Limb Threatening Ischaemia in Diabetes: Implications From Two Recent Trials. — Lin JHX, Papanas N, Zayed H, Vas PRJ The international journal of lower extremity wounds (2025)
    54. [54]
      Managing incisional wounds with Prevena VAC therapy in lower-extremity vascular surgery: A comparative study. — Kasten K, Yang A, Shaffer L, Kociola S, Holland C, Roche FA et al. Vascular (2025)
    55. [55]
      5-years patency results of Zilver PTX on the femoro-popliteal arterial segment: A Northern Sydney experience. — Saricilar EC, Anning N, Gatmaitan R, Patel K, Fisher C, Puttaswamy V Vascular (2025)
    56. [56]
      Antegrade Femoral Puncture Using a Suture-Mediated Closure Device in Infrainguinal Endovascular Interventions. — Mastrorilli D, Forcella E, Miccoli T, De Massari C, Garriboli L Annals of vascular surgery (2025)
    57. [57]
      Analysis of Lower Extremity Amputations from the SerbVasc Registry. — Tanaskovic S, Ilijevski N, Koncar I, Matejevic D, Popovic M, Stefanovic Z et al. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2025)
    58. [58]
      Magnetic Resonance Imaging - Derived Psoas Muscle Area and Survival in Patients Treated Invasively for Peripheral Arterial Disease. — Söderlund M, Huhtamo H, Protto S, Hernesniemi JA, Vakhitov D, Oksala N et al. Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society (2025)
    59. [59]
      Poor adherence to ultrasound surveillance is associated with infrainguinal bypass graft failure - An ongoing challenge in Australia. — Koo MPM, Bookun HR Vascular (2025)
    60. [60]
      Cilostazol after endovascular therapy for femoropopliteal peripheral arterial disease: A systematic review and meta-analysis. — Cerecedo CD, Silva A, Alia VS, Vargas A, Garza A, El Shazly O et al. Journal of vascular surgery (2025)
    61. [61]
      Meta-Analysis of Duplex Surveillance Following Lower Limb Endovascular Intervention. — McKenna M, Elghazaly H, Bergman H, Wingate L, Robbins D, Davies AH et al. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2025)
    62. [62]
      Efficacy of retrograde revascularization in diabetic patients with chronic limb-threatening ischemia after a failed antegrade approach. — Nezzo M, Meloni M, Carini A, Carreri B, Nicita F, Garaci F et al. Vascular (2025)
    63. [63]
      Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach. — Regan C, Scierka LE, Dardik A, Tonnessen B, Iyad Ochoa Chaar C, Ionescu C et al. Vascular (2025)
    64. [64]
      Can simultaneous coronary and peripheral angiography alter the treatment planning in Fontaine stage IV peripheral arterial disease? — Vaezzadeh K, Tayebi P, Jalali SF, Hedayati Goudarzi MT, Jafaripour I, Ziaie N et al. Vascular (2025)
    65. [65]
      In-Stent Restenosis in Peripheral Arterial Disease: Ultra-High-Resolution Photon-Counting Versus Third-Generation Dual-Source Energy-Integrating Detector CT Phantom Study in Seven Different Stent Types. — Dachs TM, Hauck SR, Kern M, Klausenitz C, Hoffner M, Schernthaner M et al. Cardiovascular and interventional radiology (2025)
    66. [66]
      Perioperative complications of minor and major reinterventions for peripheral arterial disease. — Huttler JJ, Satam KK, Kim TI, Zhuo H, Zhang Y, Aboian E et al. Vascular (2025)
    67. [67]
      Prophylactic Incisional Negative Pressure wound therapy (NPWT) for major Amputations (PINTA): protocol for randomized controlled trial of single-use NPWT devices for closed-incision major lower extremity amputations. — Power Foley M, Fahey C, Byrne AM, Leahy R, Dempsey L, Westby D et al. BJS open (2025)
    68. [68]
      Is plasma atherogenic index or LDL/HDL ratio more predictive of peripheral arterial disease complexity? — Evsen A, Aktan A, Altunova M, Özbek M Vascular (2025)
    69. [69]
      Twelve-Month Outcomes of Intravascular Lithotripsy for Treatment of Calcified Popliteal and Infrapopliteal Lesions in Patients With Chronic Limb-Threatening Ischemia. — Nugteren MJ, Hazenberg CEVB, Akkersdijk GP, van den Heuvel DAF, Schreve MA, Ünlü Ç Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2025)
    70. [70]
      Collateral vessel size and number could predict severe dissection after balloon angioplasty in patients with femoropopliteal artery chronic total occlusion. — Acar E, Donmez I, Güneş Y, Sincer I, Izgi IA Vascular (2025)
    71. [71]
      Open and endovascular treatment of the common femoral artery in a tertiary care center. — Wells N, Hundito A, Tuttle M, Alameddine D, Aboian E, Arhuidese I et al. Journal of vascular surgery (2025)
    72. [72]
      Serum Irisin as a Predictor for Peripheral Arterial Disease: Insights from a Clinical Study. — Cao Y, Wei T, Li Y, Duan H Annals of vascular surgery (2025)
    73. [73]
      Ankle-Brachial Index: Diagnostic Tool of Peripheral Arterial Disease and Predictor of Cardiovascular Risk-An Update of Current Knowledge. — Poredos P, Stanek A, Catalano M, Boc V Angiology (2025)
    74. [74]
      Muscle tissue oxygenation in individuals with peripheral arterial disease of different walking abilities: An exploratory study. — Przybysz GMP, Geisel PP, de Oliveira Nascimento I, Monteiro DP, Pedrosa R, Pereira DAG Microvascular research (2025)
    75. [75]
      Thirty-day outcomes from the Disrupt PAD BTK II study of the Shockwave Intravascular Lithotripsy System for treatment of calcified below-the-knee peripheral arterial disease. — Chandra V, Lansky AJ, Sayfo S, Shammas NW, Soukas P, Park J et al. Journal of vascular surgery (2025)
    76. [76]
      Trends in Utilization of Common Tests and Procedures in Treating Peripheral Arterial Disease in the Medicare Population from 2011 to 2021. — Tsiouplis NJ, Reeves RA Journal of vascular and interventional radiology : JVIR (2025)
    77. [77]
      Long-term outcomes of below-the-knee bypass surgery using heparin-bonded expanded polytetrafluoroethylene grafts. — Yamamoto Y, Uchiyama H, Oonuki M, Tsukuda K, Kazama A, Wada Y et al. Surgery today (2025)
    78. [78]
      Peripheral Arterial Ultrasound. — Needleman L, Feld R Radiologic clinics of North America (2025)
    79. [79]
      Feasibility and Safety of Endovascular Interventions via Percutaneous Access to the Axillary Artery. — Alterman CD, Perera AD, Gupta PK, Alterman DM Annals of vascular surgery (2025)
    80. [80]
      Contemporary Medical Management of Peripheral Arterial Disease. — Cook IO, Chung J Cardiovascular drugs and therapy (2025)
    81. [81]
      Enhancing vascular surgery outcomes through geriatric co-management: a study on the impact of the POPS team. — Bakheet M, Hughes M, Darwish N, Chen S, Egun A, Banihani M Annals of the Royal College of Surgeons of England (2025)
    82. [82]
      Factors Associated With Myocardial Infarction in a Rural Population With Peripheral Arterial Diseases. — Awujoola AO, Mokikan MT, Odebunmi OO, Mamudu HM, Stewart DW, Husari G et al. Angiology (2025)
    83. [83]
      Angiosome-Guided Revascularization in Local Flap Reconstruction of the Foot and Ankle: Comparable Outcomes With Both Direct and Indirect Revascularization. — Rohrich RN, Li KR, Lava CX, Akbari CM, Attinger CE Annals of plastic surgery (2025)
    84. [84]
      The Ability of Clinical Decision Rules to Detect Peripheral Arterial Disease: A Narrative Review. — Rerkasem A, Nopparatkailas R, Nantakool S, Rerkasem R, Chansakaow C, Apichartpiyakul P et al. The international journal of lower extremity wounds (2025)
    85. [85]
      Protocolized approach saves the limb in peripheral arterial injury: A decade experience. — Priyadarshini P, Kaur S, Gupta K, Kumar A, Alam J, Bagaria D et al. Chinese journal of traumatology = Zhonghua chuang shang za zhi (2025)
    86. [86]
      The Relationship Between the Global Limb Anatomic Staging System and Midterm Outcomes of Subintimal Angioplasty of Superficial Femoral Artery Atherosclerotic Disease in Chronic Limb Threatening Ischemia. — Shahat M, Atalla K, Abdelmonem M, Khairy A Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2025)
    87. [87]
      A Novel Endovascular Robotic System for Treatment of Lower Extremity Peripheral Arterial Disease: First-in-Human Experience. — Guo W, Song C, Bao J, Xia S, Zhang L, Wang K et al. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2025)
    88. [88]
      Factors effecting the success of retrograde tibiopedal access and recanalization in infrapopliteal artery occlusions. — Gündoğmuş CA, Özen Atalay H, Samadli V, Oğuzkurt L Diagnostic and interventional radiology (Ankara, Turkey) (2025)
    89. [89]
      Risk factors and rates of revision amputation following ischemic lower major limb amputations: A 10-year retrospective analysis. — Selçuk E, Erem M, Yıldırım S, Çopuroğlu C, Çiftdemir M, Erkal D Joint diseases and related surgery (2025)
    90. [90]
      Cardiometabolic and molecular adaptations to 6-month intermittent fasting in middle-aged men and women with overweight: secondary outcomes of a randomized controlled trial. — Barve RA, Veronese N, Bertozzi B, Tosti V, Cagigas ML, Spelta F et al. Nature communications (2025)
    91. [91]
      A Diagnostic Comparison Study between Maximal Systolic Acceleration and Acceleration Time to Detect Peripheral Arterial Disease. — Willems SA, van Bennekom OO, Schepers A, van Schaik J, van der Vorst JR, Hamming JF et al. Annals of vascular surgery (2025)
    92. [92]
      Insights From the FDA's MAUDE Database Regarding the Real-World Safety of Jetstream Atherectomy for Peripheral Arterial Disease. — Min A, Alkhalifa F, Ahrari A, Healy G, Jaberi A, Tan KT et al. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2025)
    93. [93]
      Sarcopenia is a possible risk factor for amputation after peripheral arterial interventions. — Dağlı M, Gül EB, Yiğit G, Gevrek M, Yılmaz M, Özen S et al. Vascular (2025)
    94. [94]
      Comparative Analysis of Mortality and Amputation Rates in Patients Undergoing Atherectomy for Infra-Popliteal Peripheral Arterial Disease: Insight From the VQI. — Jamil Y, Nanna MG, Chaar CIO, Mena-Hurtado C, Attaran RR Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2025)
    95. [95]
      The Additional Value of Activated Clotting Time-Guided Heparinization During Interventions for Peripheral Arterial Disease. — Roosendaal LC, Radović M, Hoebink M, Wiersema AM, Blankensteijn JD, Jongkind V Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2025)
    96. [96]
      Outcomes of drug-coated balloon angioplasty in patients with dyslipidemia in the BIOLUX P-III registry: A subgroup analysis. — Dodd JE, Hanna J, Brodmann M, Golledge J, Zeller T, Moscovic M et al. Vascular (2025)
    97. [97]
      Effect of evolocumab in patients with chronic limb threatening ischemia (Evol-CLI study). — Dhillon AS, Caro J, Choi J, Caro JA, Rowe V, Kumar SR et al. Cardiovascular revascularization medicine : including molecular interventions (2025)
    98. [98]
      Nutritional habits in patients with peripheral arterial disease: Adherence to the mediterranean diet. — Vilalta Doñate E, García Fernández F, Martínez Meléndez S, Castillo Castillo C, Salas Medina P, Almodóvar Fernández I Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis (2025)
    99. [99]
      Interaction and combined effect of triglyceride-glucose index and hypertension on type 2 diabetes individuals' peripheral arterial disease risk. — Gong C, Chen C, Zhao Y, Wang Y, Li K, Lv X et al. Acta diabetologica (2025)
    100. [100]
      Female gender is independently associated with longer hospital stays following infra-inguinal bypass for peripheral arterial disease. A retrospective cohort study. — Farndon DJ, Vulla S, Bennett PC Vascular (2025)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG